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Abstract: Increased fragility of long bones and delay in fracture healing in adults as well as skeletal development disorders in children
are thought to be associated with endochondral ossification problems. The extracellular matrix (ECM) of cartilage is absorbed during
endochondral ossification. During the recovery process from damage, chondrocytes undergo hypertrophy and increase their cell volume; on
the other hand, it is also necessary to digest the ECM elements around the cells. Recent research on the proteolytic enzymes in ECM assumed
to be responsible for the digestion is connected to proteinases digesting type II collagen and aggrecan. ADAMTS1, 4, and 5 are known as
major aggrecanases within the matrix metalloproteinase (MMP) enzymes in human cartilage. These are regarded as main determiners
among MMPs of bone growth, healing, and remodeling. In this mini review article, the remodeling and restoration of osseous tissue in
type-1 and -2 diabetes mellitus (DM) and the effect of insulin on these processes are discussed briefly in the light of the current literature.
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1. Introduction
Glucose is an essential nutrient in terms of metabolism and
structural needs in the hyaline cartilage and bone growth
centers. Glucose is a primer substrate for the production
of ATP for the chondrocytes in an anaerobic environment;
moreover, it is also the source of glucosamine sulfate for
the development, protection, repair, and remodeling of
cartilage (Mangiavini et al., 2014). Decrease in linear growth
in the skeletal system and abnormalities in the insulin-like
growth factor-1 (IGF-1) axis were noted in children with
uncontrolled type-1 diabetes mellitus (type-1 DM) (Chiarelli
et al., 2004; Bizzarri et al., 2014). In these patients, some
health problems occur during growth and development
during the period of entry into adolescence. On the other
hand, patients with type-2 DM are known to have problems
with wound healing, bone resistance, healing of fractured
bones, and poor recovery from tooth implant surgery.
The fact that insulin stimulates matrix synthesis
suggests modulation of chondrocyte metabolism via
multiple biosynthetic/receptor pathways (Glade et al.,
1994). Insulin is recognized by all target organs via
the insulin receptor (IR) and IGFR-1. IGF-1, a major
stimulator of matrix synthesis in cartilage, is likely to play
a role in replacing lost or damaged cartilage matrix during
* Correspondence: sumeyyaak@hotmail.com

bone remodeling (Martin et al., 2000). Bone formation
and remodeling is a dynamic process that requires energy
expenditure. Therefore, one of the major targets for insulin
signaling is bone cells. A molecule obligatory for bone
tissues, Runx2, was found to be induced in 3T3-L1 cells
(Adhami et al., 2011). Runx2-null cells were at an elevated
state of energy metabolism and addition of insulin resulted
in a marked suppression of genes required for insulin
signaling. The suppression was observed at all stages of the
insulin pathway (receptors, transducers, nuclear effectors,
and target genes) (Adhami et al., 2011).
2. The effects of type-1 and -2 DM on physiological and
pathological processes of connective tissue
2.1. Skeletal growth
One of the most important results in children with
untreated type-1 DM is somatic growth retardation
(Maor and Karnieli, 1999; Giannini et al., 2014), because
insulin has a central role in the main regulation of the
GH/IGF axis. Successful insulin regimens applied to this
type of patient have the advantage of more physiological
circulating insulin concentrations, resulting in improving
GH/IGF alterations. Overweight children are taller than
their normal weighted peers (Stovitz et al., 2010; Olza et
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al., 2014). The skeletal growth in these children occurs at
an earlier stage and they reach adolescence at earlier ages.
Although clinical and experimental evidence support the
growth-promoting properties of insulin (Fennoy et al.,
2013), it is not yet known whether insulin resistance or
hyperinsulinemia is responsible for rapid structural growth
and skeletal maturation in children. It is found in mice
fed a high-fat diet that insulin resistance and accelerated
skeleton growth are related. During in vitro experiments,
it is shown that insulin itself directly modulates skeleton
growth in the growth plate by activating insulin receptors
(Phornphutkul et al., 2006). Regarding type-2 DM,
insulin resistance has been suggested to be a core defect
in the pathophysiology of obesity-related comorbidities in
children (Shaibi et al., 2006). However, it has been shown
that exercise training can improve insulin resistance and
reduce the risk of type-2 DM in adults. It is not known
whether exercise has an effect on insulin resistance in
children (Shaibi et al., 2006).
2.2. Difficulties in dental operations
Maxillary sinus graft application is claimed to be
contradictory when used for tooth implants in patients
with uncontrolled DM (Nevins et al., 1998). It is found in
animal studies that type-1 DM decreases bone formation
and results in osteopenia and delayed fracture healing (Lu
et al., 2003). In type-1 DM, bone formation is delayed after
fracture of the tibia and femur, and this effect was reversed
upon insulin replacement (Beam et al., 2002). The new
formation of bone areas, the number of osteoblasts, and
the amount of collagen were decreased in diabetic rats
operated on for maxillary sinus graft (Hou et al., 2012).
Serum osteocalcin levels were also found to be decreased.
Insulin application leads to an increase in osteogenesis.
It demonstrates that decreased bone formation in type-1
DM animal models might be prevented by insulin therapy.
2.3. Bone healing
There are several components of bone fracture healing:
hematoma, migration and proliferation of progenitor cells
to the affected area, and differentiation into osteoblasts
and chondrocytes. The second classes of cells, namely
chondrocytes, manufacture the cartilage tissue, which
in turn produces first cartilaginous and then calcified
tissue. In the environment, osteoblasts start to form
endochondrial bone. The reason for osteopenia in type1 DM is the decreased bone mineral density and bone
formation (Gerstenfeld et al., 2005). Patients with type1 and -2 DM also display prolonged wound healing
compared to healthy counterparts (Chaudhary et al.,
2008). Both type-1 and -2 DM are accepted as among
the main metabolic disorders, increasing fracture
predisposition and impairing fracture healing as a
consequence of hyperglycemia and increased advanced
glycation end products formation, ROS generation, and
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inflammation (Jiao et al., 2015). It was reported that the
adverse effects of type-2 DM on bone healing in rats are
mainly attributed to the improving osteoblast functioning
and bone formation processes (Hamann et al., 2011).
Moreover, suppressed osteoblastogenesis as a cause and
mechanism for low bone mass and impaired bone healing
is also a challenge for type 2 DM. Contrary to the common
belief, cartilage metabolism is the main crucial determiner
of fracture healing rather than bone metabolism in terms
of the beginner events in the healing process of bone
fractures. The subject is rather original, and needs to be
studied in type-1 and -2 DM since the process is delayed,
and differentiation and proliferation decline in type-1 and
-2 DM (Gandhi et al., 2005).
Contemporary findings in the regeneration and
restoration of bone remodeling emphasize matrix
metalloproteinases (MMPs) because mice lacking these
MMPs have huge defects in bone machinery (Aiken et al.,
2010; Uysal et al., 2013). The way the MMPs works is a
simple one: they cut their own substrates at certain points.
They are also responsible for communications between
certain bone cells.
3. A disintegrin-like and metalloproteinase with
thrombospondin type-1 motifs (ADAMTS)
ADAMTS enzymes (Akyol et al., 2015b) are divided
into three classes according to their capacity to break the
aggrecan molecule: Aggrecanase-1: ADAMTS1 and 4;
Aggrecanase-2: ADAMTS5; Aggrecanase-3: ADAMTS8, 9,
and 15. Of those, ADAMTS4 and 5 show the most powerful
aggrecanase activities (Tortorella et al., 1999; Rogerson et
al., 2008). It has been proven that ADAMTS proteins play
crucial roles in growth development, the metabolism of
the cartilage extracellular matrix (ECM), and progression
of joint diseases (Arner et al., 2002). ADAMTS4 and 5 are
known as major aggrecanases within the MMP in human
cartilage. The activation process of this naturally found
zymogen enzyme is not entirely known, and needs to be
clarified. Although the roles of ADAMTS in chondrocyte
growth, differentiation, and maturation on the epiphyseal
plate are known to an extent, their roles in endochondral
ossification are not fully proven yet (Demircan et al., 2005;
Hatipoglu et al., 2009; Yaykasli et al., 2009).
3.1. Direct insulin effects on ADAMTS
Researchers have shown the mRNA expression of
ADAMTS9 during the chondrogenesis of insulin-induced
ATDC5 cells with RT-PCR. As a result, ADAMTS9 is
expressed in these chondrocytes, and together with the
proliferation of chondrocytes and matrix degradation,
they help to contribute to hypertrophy of chondrocytes
and the endochondral ossification process (Kumagishi
et al., 2009). After in vitro induction of chondrogenesis
by insulin in ATDC5 cells, the ADAMTS9 expression
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is bimodally increased: the first peak occurs between
days 8 and 14 and the second between days 28 and 35.
However, the type X collagen, a marker of hypertrophic
chondrocytes expression, has shown its peak on day 22.
Type-1 and -2 DM deteriorates cartilage formation and
resorption as well as overall fracture healing extensively.
Yet, the molecular mechanism remains obscure. The effects
of insulin for these processes require both in vivo and in
vitro experimental setup studies. The relationship among
ECM formation, cartilage production, and ADAMTS
enzyme levels/activities as well as tissue inhibitory
proteins in bone formation needs to be enlightened in
both protein and mRNA levels (Demircan et al., 2013).
The main reason for increased fragility of long bones
in patients with unregulated type-1 and -2 DM may be
insulin’s absence/ineffectiveness. The reducing/activity
inhibiting effect of insulin on ADAMTS proteins detected
in our recent unpublished study ensures that the cartilage
and bone tissues under insulin depression prefer going in
an anabolic direction. In insulin absence, however, it can
be anticipated that an increase in ADAMTS activity may
accelerate the destruction of ECM in cartilage and bone
tissues leading consequently to a reduction in the resistance
to bone fractures. According to one of our previous
studies, ADAMTS6 (one of the orphan ADAMTS) mRNA
expression was found to be decreased as early as one day
after insulin application, and continued up to day 11
(Uğurcu et al., 2014). It was shown that animals with type1 DM created smaller fracture callus compared to controls
(Follak et al., 2004). The healing time interval and recovery
time are prolonged dramatically in type-1 DM (White et
al., 2003; Gandhi et al., 2005). Molecular studies revealed
that DNA amount inside healing fractures in type-1 DM
is reduced up to 40% (Brown et al., 2014), and collagen
content in newly growing callus was decreased in animals
with type-1 DM compared to normoglycemic ones (Brown
et al., 2014).
When insulin was induced into Swarm rat chondrocyte
cells, the insulin receptors increased, which is not
interpreted as an increase in the de novo receptor synthesis
or a translocation of other intracellular receptors located
in the cell compartments close to the cell surface, but most
likely as a decrease in the rate of receptor degradation (Otsu
et al., 1988). On the other hand, experiments with human
recombinant insulin by ruling out all other possibilities
have shown that increased proteoglycan synthesis is
entirely caused by insulin itself (Otsu et al., 1988).
3.2. General behavior of MMPs on ECM degradation
A loss of chondrocytes is considered physiologically
significant since the loss itself triggers the production of
several signals, which stimulates cartilage resorption.
In hypertrophic chondrocytes, MMP13, which digests
fibrillary collagen and aggrecan, is normally expressed

(Cawston et al., 2006). MMP13 knockout mice show
a phenotype in which chondrocytes undergo regular
hypertrophy leading to a delay in ossification invasion
(Inada et al., 2004). ADAMTS1, 4, and 5 knockout mice are
able to grow up normal, and do not show any defect in their
cartilaginous tissues (Little et al., 2005; Stanton et al., 2005).
Because these are the most important aggrecanases found
in the cartilage, none of them take part alone in the removal
of cartilage aggrecan in a significant role. ADAMTS1
gene is responsive to inflammation that is not expressed
in normal tissues, but it is induced by lipopolysaccharide
stimulation (Kuno et al., 1997). ADAMTS1 and 4 play a
crucial role in versican proteolysis (Sandy et al., 2001).
Procollagen and proteoglycan substrates were recognized
by ADAMTS proteases with a great specificity (Sandy et
al., 2001). Expanding chondrocytes are facilitated by some
other proteinases such as cathepsins and calpains, which
remove the cartilage ECM surroundings (Cawston et al.,
2006).
The most important extracellular cartilage compound
is aggrecan, which is a proteoglycan, providing strength
against pressure force, dynamic weight-bearing function,
and an osmotic feature (Akyol et al., 2014a). As an
incredibly complex macromolecule, aggrecan is specific
to the cartilage and intervertebral disc, and is extremely
hydrophilic, consisting of glycosaminoglycan chains
containing about 100 chondroitin sulfate units and 30
keratin sulfate chains (Hardingham et al., 1992). Normal
and osteoarthritic cartilage normally express ADAMTS4
(Yamanishi et al., 2002). If inhibited by some factors in
vitro, the collapse of aggrecan is prevented (Malfait et
al., 2002). Knockout mice with ADAMTS4 and 5 dual
deletions can phenotypically differ from the wild-type.
Numerous biological factors were determined, affecting
MMP activities including cytokines, hormones, growth
factors, and many others (Demircan et al., 2014). MMPs
have been inhibited by two types of proteinase inhibitors:
Tissue inhibitors of metalloproteinases (TIMPs) and
secreted inhibitors of metalloproteases (IMPs) (Mandal
et al., 2003). TIMPs are natural inhibitors important for
various physiological process controls. These processes
include cell invasion, angiogenesis, digestion of articular
cartilage, trophoblast implantation, inner folds formation
of mammary gland, and wound healing (Twining et
al., 1994; Demircan et al., 2014). TIMP-2 drives tissue
proteinases to stop, and thus the structure remains intact.
4. Signaling pathway of insulin in chondrosarcoma cells
Chondrosarcoma cells are one of the most convenient
cell types to study cartilage metabolism; however, the
signaling pathway of insulin in these cells has rarely been
studied to compare aggrecan degradation with others.
When insulin is supplemented to the ATDC5 cell media, it

329

AKYOL et al. / Turk J Biol

causes cell condensation and consequently chondrogenesis
(Shukunami et al., 1997). PI3K/PKB (Akt) is known to
be involved in insulin/IGF-1-induced chondrogenesis
(Hidaka et al., 2001). The activation of PI3K and PI3
production results from the phosphorylation of tyrosine
residues by insulin stimulation via insulin receptor
substrate-1 (IRS-1) (Sparks et al., 2013). Insulin/IGF-1
pathway is assigned to lead to chondrogenic differentiation
in ATDC5 cells (Hidaka et al., 2001).
Molecular, histological, and immunohistological
studies revealed that diabetes itself caused increased
osteoclastogenesis and mainly loss of cartilage and
increased elevated mRNA levels of various pro-resorptive
elements of cartilage loss. All of these parameters totally
or individually were reversed by treatment with insulin
(Kayal et al., 2009). Specifically, the impact of type-1
DM and insulin application on cartilage was examined
in the above-mentioned study. Ten days after fracture,
the normoglycemic and insulin treated diabetic animals
had 1.6-fold more cartilage than the diabetic ones. The
increased osteoclast numbers were also reversed by
insulin treatment. In type-1 DM, increased TNF-alpha
and receptor activator of nuclear factor kappa-B ligand
(RANKL) expression and rapid removal of cartilage were
observed. Upon slow release insulin treatment, these
diabetes-induced TNF-α and RANKL expressions were
reversed.
Insulin stimulates proteoglycan synthesis in the
chondrocytes by acting through the insulin receptors
(Foley et al., 1982). This effect occurs at physiological
concentrations in the Swarm rat chondrosarcoma
chondrocytes by insulin receptors themselves rather than

pharmacological concentrations. One of the reasons is that
a considerable amount of anti-insulin receptors were found
to inhibit the biological response to the insulin-like growth
factors. The other reason is that insulin at physiological
concentrations stimulates sulfate incorporation into
macromolecules in chondrocyte cultures derived from
the Swarm rat chondrosarcoma. Sulfate is needed for the
synthesis of some amino acids to be able to participate in
the synthesis of various kinds of ECM structures, which
have complex proteins (Bogdani et al., 2014).
5. Conclusion
Many studies are focused on the effects of several
molecules to elucidate the matrix biology of chondrocytes
and pathophysiology of experimental osteoarthritis
(Akyol et al., 2013, 2014b). A list of the beneficial effects
of insulin (Akyol et al., 2015a; Altuntaş et al., 2015)
discussed in detail via whether its regulating effect on
hyperglycemia or its direct effect on cells may be as follows:
accelerating fracture healing, improving resistance to
fractures, providing growth and development of skeletal
structures in children, and ensuring success with preoperational processes in dental implant surgery. Insulin
does not necessarily participate in all stages of ADAMTS
metabolism. We previously reported that insulin does
not participate in regulation of ADAMTS13 levels and/or
activities in OUMS-27 human chondrosarcoma cells (Firat
et al., 2014). Future research on ADAMTS and TIMP in
terms of gene, mRNA, and protein phases in animals with
experimentally induced type-1 DM would possibly help
show the full-scale machinery of the ECM in the cartilage.
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